Challenging Cases in PAH: A Deeper Dive

FACULTY AND PEER REVIEWER DISCLOSURES
Dr. Channick, Faculty/Content Planner: has disclosed the following relevant financial relationships:  
Consultant - Actelion, Bayer, Gossamer, Theravance
Contracted Research - Bayer
Dr. McLaughlin, Faculty/Content Planner: has disclosed the following relevant financial relationships:
Consultant - Acceleron, Actelion, Altavant, Caremark, CiVi Biopharma, Gossamer Bio, Liquida, United Therapeutics
Contracted Research - Acceleron, Actelion, Gilead, Reata Phar, SonoVie, United Therapeutics
Nadine Al-Naamani, MD, MS - Peer Reviewer: has no financial relationships to disclose.

AKH STAFF AND PLANNERS DISCLOSURES
Margaret V. Clark, MSc, RN, RRT - NPS, CMPP, Medical Writer/Interviewer: has no financial relationships to disclose.
Dorothy Caputo, MA, BSN, RN, AKH Director of Accreditation, Planner: has no financial relationships to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C, Nurse Planner/Reviewer: has no financial relationships to disclose.
Patricia Brignoni, AKH Director of Operations: has no financial relationships to disclose.
Steve Eckert, AKH President & CEO, Planner: has no financial relationships to disclose.

ATS STAFF DISCLOSURES
Suzette Machado, MPA, CHCP, Associate Director of Education Programs and Accreditation; has no financial relationships to disclose.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. ATS and AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclosure Declaration
It is the policy of ATS and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by ATS and AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Copyright 2020 ATS and AKH Inc. No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.

Privacy Policy:
https://akhcme.com/akhcme/pages/privacy